Corebridge Financial’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-101,231	Closed	-$759K	–	327
2025 Q1	$759K	Sell	101,231 -1,500	-1%	-$11.3K	﹤0.01%	1391
2024 Q4	$773K	Sell	102,731 -7,755	-7%	-$58.3K	﹤0.01%	1455
2024 Q3	$840K	Sell	110,486 -681	-0.6%	-$5.18K	﹤0.01%	1450
2024 Q2	$687K	Buy	+111,167	New	+$687K	﹤0.01%	1531